SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 552.81 |
| Enterprise Value ($M) | 152.33 |
| Book Value ($M) | -716.93 |
| Book Value / Share | -5.12 |
| Price / Book | -0.77 |
| NCAV ($M) | -1,370.53 |
| NCAV / Share | -9.79 |
| Price / NCAV | -0.40 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.35 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.67 |
| Current Ratio | 0.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,143.89 |
| Assets | 1,797.49 |
| Liabilities | 2,514.42 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 983.71 |
| Operating Income | -566.51 |
| Net Income | -545.06 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -713.97 |
| Cash from Investing | -58.81 |
| Cash from Financing | 4.47 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Shah Capital Management | 6.70 | 106.19 | |
| 13G/A | Morgan Stanley | 1.80 | -66.42 | |
| 13G/A | Vanguard Group Inc | 12.26 | 64.62 | |
| 13G/A | BlackRock Inc. | 7.10 | 75.45 | |
| 13G/A | State Street Corp | 14.12 | 60.50 | |
| 13G | SK Bioscience Co., Ltd. | 6.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 426,562 | 2,344,340 | 18.20 | |
| 600,779 | 2,613,836 | 22.98 | |
| 433,539 | 925,657 | 46.84 | |
| 420,919 | 1,106,172 | 38.05 | |
| 372,039 | 862,010 | 43.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NKTX – Nkarta, Inc. | NMRA – Neumora Therapeutics, Inc. |
| NUVL – Nuvalent, Inc. | NXTC – NextCure, Inc. |
| OGI – Organigram Holdings Inc. |